Skip to site menu Skip to page content
Logo Image
In Brief
Spotlight

Novo Nordisk puts AI at the centre of its clinical strategy

Novo Nordisk’s Ibrahim Kamstrup-Akkaoui outlines how the Danish GLP-1 giant is embedding AI into its clinical foundation.

Latest news

Eli Lilly continues dealmaking roll with $1bn AlzeCure agreement

If ACD680 were to reach the market, it would deepen Lilly’s Alzheimer’s legacy past anti-amyloid-beta therapy, Kisunla.

Dangerous waters: Geopolitics, supply chains and access to medicines

The Middle East conflict has accentuated long-standing vulnerabilities in the pharma manufacturing supply chain.

WuXi AppTec hits back after being named in Pentagon’s Chinese military list

A spokesperson for the Chinese company said “we will take immediate action” following the military designation.

MHRA to roll out new AI sandbox for medicines development 

The new MHRA sandbox will allow innovators to test AI systems to enhance medicines’ safety and predict side effects.

Aditxt and Ignite announce merger plans with strategic partner

Ignite will separate from Aditxt and is expected to become an independent public company called Ignite Proteomics.

ADA26: Early data for teplizumab demonstrates promise for slowing T1D progression

Real-world data presented at ADA 2026 showcased the impact of Sanofi's teplizumab in slowing type 1 diabetes (T1D) progression.